Cargando…
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases
BACKGROUND: Non-adherence impacts negatively on patient health outcomes and has associated economic costs. Understanding drivers of treatment adherence in immune-mediated inflammatory diseases is key for the development of effective strategies to tackle non-adherence. OBJECTIVE: To identify factors...
Autores principales: | Vangeli, Eleni, Bakhshi, Savita, Baker, Anna, Fisher, Abigail, Bucknor, Delaney, Mrowietz, Ulrich, Östör, Andrew J. K., Peyrin-Biroulet, Laurent, Lacerda, Ana P., Weinman, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662720/ https://www.ncbi.nlm.nih.gov/pubmed/26547912 http://dx.doi.org/10.1007/s12325-015-0256-7 |
Ejemplares similares
-
Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study
por: Michetti, Pierre, et al.
Publicado: (2016) -
Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review
por: Depont, Fanny, et al.
Publicado: (2015) -
Evolution of IL-23 Blockade in Inflammatory Bowel Disease
por: Danese, Silvio, et al.
Publicado: (2022) -
Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease
por: Abreu, Maria T, et al.
Publicado: (2020) -
Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise
por: Danese, Silvio, et al.
Publicado: (2021)